Marc Maynadié

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 6.2K citations · Full text

Medicine, Biostatistics, Oncology +17

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier et al. · The Lancet · 2009 · 1.1K citations

Medicine, Hematology, Immunology +11

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

Milena Sant, Claudia Allemani, Carmen Ţereanu et al. · Blood · 2010 · 958 citations · Full text

Medicine, Hematology, Pathology +16

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

Karin E. Smedby, Claire M. Vajdic, Michael O. Falster et al. · Blood · 2008 · 624 citations · Full text

Life Sciences, Immunology, Oncology +15

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

Gemma Gatta, Riccardo Capocaccia, Laura Botta et al. · The Lancet Oncology · 2017 · 503 citations · Full text

Medicine, Oncology, Cancer Control +13